Your session is about to expire
← Back to Search
Incentives for Cardiac Rehabilitation (HeLP Trial)
HeLP Trial Summary
This trial will study whether using a case manager or financial incentives (or both) can increase the number of lower socioeconomic status patients who participate in cardiac rehabilitation after a heart event.
HeLP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHeLP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HeLP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition like severe arthritis, past stroke, or lung disease that limits my ability to exercise.My severe heart rhythm problem is under control with a device.I do not have severe dementia or untreated major psychiatric disorders.I do not have a severe illness that would stop me from joining the clinical trial.I experience chest pain with minimal activity or while resting.I experience heart failure symptoms even when resting.I have recently had a heart attack, heart surgery, or been diagnosed with heart failure.
- Group 1: Incentives and Case Management
- Group 2: Usual care
- Group 3: Incentives
- Group 4: Case Management
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being selected for inclusion in this experiment?
"Affirmative, according to clinicaltrials.gov this research is still enrolling participants. It was first published on December 3rd 2018 and the most recent update occurred on September 7th 2022. 200 volunteers are needed from a single medical facility for inclusion in the study."
Has Case Management been granted clearance by the FDA?
"As this is a Phase 2 trial, our Power team has assessed the safety of Case Management to be a 2 due to limited efficacy evidence."
Is there an ongoing recruitment process for this research project?
"This study is open to participants, with the original listing being posted on December 3rd 2018 and updated most recently in September 7th 2022. The information can be found on clinicaltrials.gov."
What objectives is this trial striving to accomplish?
"The objective of this evaluation, which is due to be completed over a 4 month period from the initial assessment, is for participants to complete their Cardiac Rehabilitation program. Assessed secondary outcomes include alterations in perceived quality of life (EuroQoL) questionnaires, mental health via Adult Self-Report assessments and reported depressive symptoms recorded with the Beck Depression Inventory (BDI)."
Share this study with friends
Copy Link
Messenger